Prognostic significance of histopathological subtypes in stage I pure yolk sac tumour of the ovary
- PMID: 7510118
- PMCID: PMC1968864
- DOI: 10.1038/bjc.1994.96
Prognostic significance of histopathological subtypes in stage I pure yolk sac tumour of the ovary
Abstract
The correlation between histological subtype [endodermal sinus (ES), polyvesicular vitelline (PV), glandular (G) and hepatoid (H) subtypes] and the prognosis of pure yolk sac tumours (YSTs) of the ovary was investigated. From 1964 to 1989, 35 patients with YSTs were treated with primary surgery and adjuvant chemotherapy. The prevalence of histological subtypes was as follows: 14 patients had a single subtype, either ES (12) or G (2); 12 patients had two subtypes, ES+G (4), ES+PV (3), ES+H (4) or G+H (1); six patients had three subtypes, ES+P+H (4) or ES+G+H (2); and three patients had all four subtypes. Multivariate analysis showed that important predictors were FIGO stage, chemotherapeutic regimen and residual tumour size. However, for stage I, multivariate analysis showed that the histological subtype was a superior predictor to the subclassification of FIGO stage I, age or chemotherapeutic regimen (P = 0.03). Kaplan-Meier analysis showed that YSTs composed of an admixture of three or four subtypes was associated with a better prognosis than those composed of one or two subtypes (P < 0.01), other variables being constant.
Similar articles
-
Administration of standard-dose BEP regimen (bleomycin+etoposide+cisplatin) is essential for treatment of ovarian yolk sac tumour.Eur J Cancer. 2015 Feb;51(3):340-51. doi: 10.1016/j.ejca.2014.12.004. Epub 2015 Jan 2. Eur J Cancer. 2015. PMID: 25559616
-
Prognostic factors of patients with yolk sac tumors of the ovary.Am J Obstet Gynecol. 2001 May;184(6):1182-8. doi: 10.1067/mob.2001.113323. Am J Obstet Gynecol. 2001. PMID: 11349186
-
Prognostic factors in women treated for ovarian yolk sac tumour: a retrospective analysis of 84 cases.Eur J Cancer. 2011 Jan;47(2):175-82. doi: 10.1016/j.ejca.2010.08.012. Epub 2010 Sep 28. Eur J Cancer. 2011. PMID: 20851596
-
[Ovarian yolk sac tumour: general review].Bull Cancer. 2011 Aug;98(8):963-75. doi: 10.1684/bdc.2011.1387. Bull Cancer. 2011. PMID: 21708513 Review. French.
-
Prognosis of hepatoid yolk sac tumor in women: what's up, Doc?Eur J Obstet Gynecol Reprod Biol. 2014 Apr;175:25-9. doi: 10.1016/j.ejogrb.2013.12.029. Epub 2014 Jan 3. Eur J Obstet Gynecol Reprod Biol. 2014. PMID: 24462393 Review.
Cited by
-
Prognostic value of serum α-fetoprotein in ovarian yolk sac tumors: A systematic review and meta-analysis.Mol Clin Oncol. 2015 Jan;3(1):125-132. doi: 10.3892/mco.2014.417. Epub 2014 Sep 18. Mol Clin Oncol. 2015. PMID: 25469282 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical